bf/NASDAQ:PTCT_icon.jpeg

COM:PTCBIO

PTC Therapeutics

  • Stock

Last Close

42.89

22/11 21:00

Market Cap

2.44B

Beta: -

Volume Today

534.49K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-51.57M
-
-93.75M
81.78%
-170.45M
81.80%
-142.11M
16.63%
-79M
44.41%
-128.08M
62.13%
-251.58M
96.42%
-438.16M
74.17%
-523.90M
19.57%
-559.02M
6.70%
-626.60M
12.09%
depreciation and amortization
2.40M
-
2.23M
6.74%
2.88M
28.68%
3.29M
14.39%
17.68M
437.45%
26.09M
47.53%
32.18M
23.36%
84.87M
163.74%
64.13M
24.43%
128.84M
100.89%
236.59M
83.64%
deferred income tax
92.46K
-
-19.31M
20,985.61%
2.30M
111.93%
-199K
108.64%
199K
200%
-490K
346.23%
8.83M
1,901.84%
5.87M
33.49%
377K
93.58%
-34.28M
9,191.78%
-46.93M
36.92%
stock based compensation
8.43M
-
19.31M
129.14%
33.98M
75.97%
35.01M
3.03%
30.56M
12.71%
33.25M
8.81%
42.13M
26.71%
70.33M
66.91%
103.51M
47.19%
110.33M
6.59%
131.21M
18.92%
change in working capital
-12.31M
-
13.20M
207.18%
4.70M
64.39%
-8.96M
290.74%
13.23M
247.58%
14.21M
7.42%
20.43M
43.76%
36.91M
80.70%
-23.79M
164.45%
-85.33M
258.73%
-4.00M
95.31%
accounts receivables
-3.49M
-
-6.91M
98.08%
-14.84M
114.88%
-12.20M
17.78%
-29.59M
142.47%
11.53M
138.95%
-10.48M
190.96%
-44.99M
329.18%
-48.47M
7.73%
-1.54M
96.82%
inventory
-2.63M
-
-1.98M
24.75%
893K
145.19%
-6.45M
822.73%
-5.82M
9.78%
-3.46M
40.65%
1.84M
153.27%
1.80M
2.23%
-6.67M
470.44%
-8.18M
22.72%
accounts payables
5.18B
-
16.91M
99.67%
16.98M
0.40%
4.26M
74.92%
24.01M
463.77%
43.11M
79.53%
13.75M
68.11%
53.59M
289.82%
23.41M
56.31%
27.54M
17.64%
48.35M
75.54%
other working capital
-5.20B
-
2.40M
100.05%
-3.40M
241.86%
727K
121.39%
7.87M
983.08%
6.51M
17.27%
-1.39M
121.31%
-8.03M
478.67%
-4.01M
50.07%
-57.74M
1,339.93%
-42.63M
26.18%
other non cash items
6.05M
-
21.05M
247.97%
2.25M
89.30%
9.41M
317.53%
7.27M
22.73%
27.38M
276.70%
49.37M
80.29%
46.11M
6.60%
128.33M
178.33%
82.81M
35.48%
151.32M
82.75%
net cash provided by operating activities
-46.92M
-
-57.27M
22.06%
-124.34M
117.09%
-103.57M
16.71%
-10.06M
90.28%
-27.64M
174.68%
-98.64M
256.86%
-194.07M
96.75%
-251.33M
29.51%
-356.65M
41.91%
-158.42M
55.58%
investments in property plant and equipment
-845.73K
-
-4.66M
451.47%
-2.72M
41.68%
-1.78M
34.71%
-3.10M
74.61%
-15.53M
400.81%
-45.44M
192.59%
-55.98M
23.19%
-85.33M
52.44%
-152.46M
78.67%
-120.62M
20.88%
acquisitions net
-77.16M
-
-48.89M
36.64%
-4M
91.82%
38.13M
1,053.35%
57.12M
49.78%
128.44M
124.86%
86.06M
32.99%
purchases of investments
-156.04M
-
-247.80M
58.80%
-223.76M
9.70%
-85.38M
61.84%
-81.37M
4.70%
-68.61M
15.67%
-494.07M
620.07%
-1.45B
193.41%
-543.27M
62.52%
-75.55M
86.09%
-212.48M
181.25%
sales maturities of investments
29.06M
-
107.30M
269.21%
205.67M
91.68%
191.63M
6.82%
174.75M
8.81%
90.42M
48.26%
156.27M
72.82%
944.09M
504.14%
847.78M
10.20%
518.19M
38.88%
156.37M
69.82%
other investing activites
-38.13M
-
-57.12M
49.78%
-128.44M
124.86%
-86.06M
32.99%
net cash used for investing activites
-127.83M
-
-145.17M
13.56%
-20.81M
85.66%
104.48M
602.05%
13.12M
87.45%
-42.61M
424.87%
-387.24M
808.73%
-561.55M
45.01%
219.18M
139.03%
290.18M
32.39%
-176.74M
160.91%
debt repayment
-5.00M
-
-49K
99.02%
-11.67M
-
-46.16M
295.66%
-2.22M
95.18%
-151.28M
6,701.98%
-381.93M
152.47%
common stock issued
131.65M
-
235.98M
79.25%
2.47M
-
117.92M
4,677.80%
323.76M
174.56%
28.09M
91.32%
23.10M
17.77%
50M
116.44%
29.99M
40.01%
common stock repurchased
dividends paid
other financing activites
60.79M
-
1.20M
98.03%
154.06M
12,781.35%
968K
99.37%
41.75M
4,213.02%
13.65M
67.29%
301.12M
2,105.20%
686.78M
128.08%
269.23M
-
998.34M
270.82%
net cash used provided by financing activities
187.44M
-
237.13M
26.51%
154.06M
35.03%
968K
99.37%
44.22M
4,467.98%
131.57M
197.55%
613.21M
366.07%
668.72M
9.05%
20.88M
96.88%
167.95M
704.48%
646.40M
284.87%
effect of forex changes on cash
-350K
-
-639K
82.57%
-1.58M
147.89%
6.20M
491.35%
-3.61M
158.25%
-1.30M
63.92%
7.69M
690.02%
-7.82M
201.73%
-2.77M
64.56%
3.11M
212.34%
net change in cash
12.69M
-
34.33M
170.59%
8.27M
75.90%
299K
96.39%
53.47M
17,783.28%
57.71M
7.92%
126.03M
118.40%
-79.22M
162.85%
-19.09M
75.90%
98.71M
616.95%
314.17M
218.28%
cash at beginning of period
2.73M
-
15.41M
465.51%
49.75M
222.75%
58.02M
16.63%
58.32M
0.52%
111.79M
91.68%
169.50M
51.62%
295.53M
74.35%
216.31M
26.80%
197.22M
8.83%
279.83M
41.89%
cash at end of period
15.41M
-
49.75M
222.74%
58.02M
16.63%
58.32M
0.52%
111.79M
91.68%
169.50M
51.62%
295.53M
74.35%
216.31M
26.80%
197.22M
8.83%
295.93M
50.05%
594.00M
100.73%
operating cash flow
-46.92M
-
-57.27M
22.06%
-124.34M
117.09%
-103.57M
16.71%
-10.06M
90.28%
-27.64M
174.68%
-98.64M
256.86%
-194.07M
96.75%
-251.33M
29.51%
-356.65M
41.91%
-158.42M
55.58%
capital expenditure
-845.73K
-
-4.66M
451.47%
-2.72M
41.68%
-1.78M
34.71%
-3.10M
74.61%
-15.53M
400.81%
-45.44M
192.59%
-55.98M
23.19%
-85.33M
52.44%
-152.46M
78.67%
-120.62M
20.88%
free cash flow
-47.77M
-
-61.94M
29.66%
-127.06M
105.14%
-105.34M
17.09%
-13.16M
87.50%
-43.17M
227.95%
-144.08M
233.74%
-250.05M
73.55%
-336.66M
34.64%
-509.11M
51.22%
-279.04M
45.19%

All numbers in (except ratios and percentages)